Search


Current filters:


Clear current filters  or Add more filters

View Option



Results 1-10 of 14 (Search time: 0.023 seconds).

  Glibenclamide improves postprandial hypertriglyceridaemia in type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels (Journal article)

  Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study (Journal article)

  Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients (Journal article)

  Effect of barnidipine on blood pressure and serum metabolic parameters in patients with essential hypertension: a pilot study (Journal article)

  Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia (Journal article)

  Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis (Journal article)

  Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia (Journal article)

  The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes (Journal article)

  A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia (Journal article)

  Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes. Role of the lipoprotein-associated phospholipase A2 and the effect of atorvastatin treatment (Journal article)